KCM
TMO icon

Karsch Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Karsch Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$2.63M Sell
28,590
-220,949
-89% -$20M 3.12% 19
2013
Q2 		$21.1M Buy
+249,539
New +$20.8M 1.79% 22

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Karsch Capital Management's TMO Position: Q3 2013 in Review

Karsch Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 89% in Q3 2013, selling an estimated $20M and leaving 28,590 shares worth $2.63M. The position accounts for 3.12% of the portfolio, ranked #19.

Karsch Capital Management first reported a position in TMO in Q2 2013 and has held it in 2 quarters since. The position peaked at $21.1M in Q2 2013. 817 funds tracked by Wall St. Rank hold TMO as of Q3 2013.

  • Karsch Capital Management held 28,590 shares of Thermo Fisher Scientific worth $2.63M as of Q3 2013.
  • Karsch Capital Management sold 220,949 Thermo Fisher Scientific shares in Q3 2013, an estimated $20M.
  • Thermo Fisher Scientific made up 3.12% of Karsch Capital Management's portfolio in Q3 2013, its #19 holding.
  • Karsch Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 2 quarters since.
  • Karsch Capital Management's Thermo Fisher Scientific position peaked at $21.1M in Q2 2013.
  • 817 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2013.

Based on Karsch Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.